BiomarkersHumans
Clinical Evaluation of Blood‐Based Assays for Rapid Detection of Amyloid‐β Pathology in Alzheimer's Disease (CLEAR‐AD)
AAIC 2025 Abstract
Abstract
Background: Blood‐based biomarkers show promise in predicting Alzheimer's disease (AD) pathology and progression; however, inconsistencies in detection standards hinder clinical application. A head‐to‐head comparison of commercially available biomarkers is crucial for optimizing the clinical pathway for AD screening and diagnosis.
The paper
Xinyi Lyu, Feng Gao, Xiaodong Pan, Jiong Shi
Show 14 more authors
Guoping Peng, Shuting Z, Qianhua Zhao, Fang Xie, Huayan Liu, Haining Zhang, Wei Chen, Mengya Xing, Yuesong Pan, Qidong Chen, Yiming Wang, Zengshi Lin, Xiaochun Chen, Yong Shen,University of Science and Technology of China
AAIC 2025 Abstract · 24 Dec 2025 · CC BY
Presented at AAIC 2025
